Ypsomed has unveiled a pre-filled autoinjector designed for automated disassembly, streamlined recycling, and an 87% reduction in material-related CO2 emissions compared to conventional alternatives.
The YpsoLoop platform intends to match the convenience of a pre-filled, two-step autoinjector while unlocking more efficient recycling. It comprises two mono-material, bio-based subassemblies, one for the syringe unit and another for the drive unit; this is set to simplify the industrial separation, recovery, and recirculation of materials.
Its ergonomically shaped cap is expected to ensure easy removal, especially among users with limited dexterity. It also utilizes Ypsomed’s ClickGuide technology, which provides acoustic feedback throughout the injection process. Internal usability studies have apparently proven that this feature helps users maintain the recommended holding time and lowers the risk of early lift-offs.
Ypsomed hopes that these features will boost user confidence in self-administration, ensure safe and consistent dosing, and improve adherence across different patient groups.
Additionally, YpsoLoop is intended for full integration into existing fill/finish and assembly setups, alongside existing supply chain infrastructure. It is said to support industry-standard primary containers, packaging, and supply chain logistics, which is anticipated to protect existing investments while helping partners meet evolving regulatory standards and market expectations.
The autoinjector is available in 1ml and 2.25ml versions. Ypsomed plans to support its pharmaceutical partners in preparing for implementation, accessing the necessary return and recycling systems, and building the required disassembly technology for a circular process.
“With YpsoLoop, we are taking an important step toward a more circular approach in healthcare,” says Ulrike Bauer, chief business officer at Ypsomed. “Achieving circularity requires collaboration across the entire value chain – from device manufacturers and pharma partners to patients.
“This platform provides the basis for sustainable self-injection solutions that combine usability, safety, and environmental responsibility.”
In a similar development, Stevanato Group recently unveiled a customizable pen injector for the pharmaceutical industry. It features pre-injection dose indication to avoid underdosing, dial back for dose error correction, and visual and audible feedbacks for dose setting and injection.
Vetter has also updated its V-OVS syringe closure system for sterile injectables. As well as downsizing to match smaller syringes, it aimed for tamper evidence, a new locking mechanism, and updated gripping surfaces for improved opening and handling.
If you liked this story, you might also enjoy:
The ultimate guide to the Packaging and Packaging Waste Regulation in 2025
How are the top brands progressing on packaging sustainability?
Everything you need to know about global packaging sustainability regulation in 2025
The key to increasing the use of reusable packaging in supermarkets
No comments yet